Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research
The Michael J. Fox Foundation's BFDN grant supports early career researchers whose neurodegenerative disease projects were disrupted by changes in U.S. federal funding.
Funder: Michael J. Fox Foundation for Parkinson's Research
Due Dates: July 30, 2026 (LOI) | October 30, 2026 (LOI) | January 29, 2027 (LOI) | April 30, 2027 (LOI)
Funding Amounts: Up to $250,000 total for 3–12 months; institutional cost sharing up to 25% required.
Summary: Supports early career researchers whose neurodegenerative disease projects were disrupted by changes in U.S. federal funding, enabling continued progress in Alzheimer’s and Parkinson’s research.
Key Information: LOI is required; only projects disrupted by federal funding changes are eligible.
Description
This program, offered by the Michael J. Fox Foundation for Parkinson's Research in partnership with the Alzheimer’s Association, provides bridge funding to early career investigators whose research in Alzheimer's, Parkinson's, or related neurodegenerative disorders has been disrupted due to changes in U.S. federal research funding. The grant is designed to maintain research momentum and career continuity for promising scientists affected by delayed reviews, terminated grants, shifting federal priorities, or funding gaps. Funding supports direct research costs, including salary and essential lab resources, for projects that advance understanding or treatment of Alzheimer's, Parkinson's, Frontotemporal Dementia, Dementia with Lewy Bodies, and related conditions.
